Self-efficacy is a known predictor for behavior change. Little is known about the association of self-efficacy with walking ability in individuals with diabetes mellitus and peripheral arterial disease (PAD). The objective of this study was to determine the association of self-efficacy with walking ability in individuals with diabetes mellitus and PAD. In this cross-sectional study, baseline data were analyzed from individuals with diabetes mellitus type 1 or 2 and PAD who were enrolled in a walking intervention clinical trial. As part of the baseline assessment, individuals completed questionnaires to ascertain self-efficacy and co-existing illnesses. In addition, participants completed a treadmill walking test and a 6minute walking test. A total of 145 individuals were enrolled (mean age 66.5 ± 10.1 years) with diabetes mellitus and PAD; 45 (31%) were women. The mean ankle-bracial index was 0.70 (range − 0.18-2.20) and the mean glycosylated hemoglobin value was 7.1 (SD 1.2). The mean distance walked, as per the treadmill walking test, was 418 meters (SD 258) and the mean distance walked, as per the 6-minute walking test, was 272 meters (SD 74). As measured by the treadmill walking test and the 6-minute walking test, self-efficacy was associated with treadmill walking distance, coefficient 33.0 (95% CI 11.0, 55.1; p = 0.0036), and the 6-minute walking test, coefficient 10.4 (95% CI 3.0, 17.7; p = 0.0061), after adjusting for comorbidities, social habits, and disease severity. In conclusion, self-efficacy, a psychosocial mediator for behavior change, was significantly associated with walking ability in individuals with diabetes mellitus and PAD. Future studies should determine the benefits of targeting self-efficacy to improve adherence to walking therapy in patients with PAD.
Introduction
Among patients with diabetes mellitus aged 50 years or older, the prevalence of peripheral arterial disease (PAD)atherosclerosis of the abdominal aorta and arteries of the lower extremities -is as high as 29%. 1 Modification of atherosclerotic risk factors is a core component in the management of PAD. Walking is an additional component in the management of PAD as it improves lower limb function (e.g. walking distance, speed, and stair climbing). A challenge for clinicians when recommending walking therapy for patients with PAD is the motivation of a given patient to adhere to this behavior, particularly unsupervised walking therapy.
The Social Cognitive Theory (SCT) postulates multiple influences on behavior, including both cognitive and social variables. 2 One construct frequently associated with SCT is self-efficacy. Self-efficacy is an important mediator for behavioral interventions. 3 Bandura 2 conceptualizes selfefficacy as one's confidence in being able to carry out a specific behavior. 4, 5 Related to physical activity, self-efficacy refers to one's confidence to be physically active in certain situations. 6 Physical activity is important in the management of atherosclerotic risk factors (e.g. diabetes mellitus) and vascular disease. In this paper, we hypothesize that self-efficacy is associated with walking ability in individuals with diabetes mellitus and PAD (Figure 1 ).
Methods
Participants were enrolled in a randomized clinical trial, funded by the American Diabetes Association, which seeks to determine the role of a self-managed walking intervention to improve walking distance at 6 months in individuals with diabetes mellitus and PAD. For this paper, the participants were not randomized. Instead, we used baseline data of all participants combined into one group to determine the association between self-efficacy and walking ability. Results based on randomization of participants will be published in subsequent manuscripts once all the data have been collected and analyzed. The study was approved by the University of Minnesota Institutional Review Board.
The primary outcomes were mean maximal treadmill walking distance and mean 6-minute walking distance. The primary independent variable was self-efficacy as captured using the six-item Self-Efficacy for Managing Chronic Disease scale. 7 This instrument covers domain such as symptom control, role function, emotional functioning, and communicating with physicians, which are all relevant to chronic diseases. This instrument was tested on 605 subjects with chronic disease with a resultant internal consistency reliability coefficient of 0.91. 7 Additional independent variables include sociodemographics (Lifestyle and Clinical Survey), 8 walking impairment scores (Walking Impairment Questionnaire [WIQ]), 9 health-related quality of life (Medical Outcomes Study Short Form 36-Item), 10 exercise behaviors (Exercise Behaviors Scale), 7 and depressive symptoms score (Geriatric Depression Scale). 11 
Inclusion criteria
We enrolled men and women aged 40 years and older with a diagnosis of PAD and diabetes mellitus type 1 or 2. The diagnosis of PAD was based on a resting or post-exercise ankle-brachial index (ABI; ratio of systolic blood pressure in the ankle to that in the arm) of < 0.90, a toe index ≤ 0.7, or prior surgery for PAD with continued exertional leg symptoms which did not include joint pain. Independent of prior leg surgery, at the time of enrollment, participants must have reported leg symptoms as captured by the San Diego Claudication Questionnaire. 12 
Exclusion criteria
We excluded participants with at least one of the following: no available phone number, a prior major amputation (e.g. foot or lower leg), critical leg ischemia (i.e. ABI < 0.40 without an assessment by vascular surgery and non-palpable femoral pulses; tissue loss; gangrene; or ulcers), lower extremity revascularization within 6 months prior to enrollment, or absence of leg symptoms. Because of possible adverse consequences of exercise, we also excluded patients with exercise tolerance limited by leg pain of non-vascular origin or by factors other than leg pain (i.e. arthritis, dyspnea, dizziness, angina > class 2, and chronic obstructive pulmonary disease limiting exertion). Additional exclusion criteria included a myocardial infarction within the preceding 3 months, evidence of significant coronary ischemia at a low workload as ascertained via exercise treadmill testing, a systolic blood pressure greater than 180 mmHg or diastolic pressure greater than 110 mmHg, a diagnosis of a lifethreatening malignancy within the past year, and no intention to start exercising in the next 6 months.
Assessments
Eligibility assessed by telephone To assess eligibility for study participation, we conducted telephone interviews of a participant's medical history and we administered a survey to ascertain concerning symptoms that would preclude involvement in physical activity. We also ascertained the presence of leg symptoms and current intentions for the use of regular exercise.
Physical Activity Readiness Questionnaire (PAR-Q) We used the Physical Activity Readiness Questionnaire (PAR-Q) to determine the presence of concerning symptoms (e.g. chest pain, shortness of breath). 13 The seven-item questionnaire detects relevant problems, and a 'yes' response to any item indicates the need for further evaluation by a physician prior to starting any form of exercise.
The San Diego Claudication Questionnaire (SDCQ) The San Diego Claudication Questionnaire (SDCQ), 12 a nine-item questionnaire that can be completed within 5 minutes, was used to define leg symptoms (i.e. no pain, atypical leg pain, intermittent claudication); it is 40.4% sensitive and 88.1% specific for PAD.
Patient-Centered Assessment and Counseling for Exercise
To assess intentions to routinely exercise, we administered Part 1 of the previously developed Patient-Centered Assessment and Counseling for Exercise (PACE) protocol. 14 Part 1 of the PACE protocol is a one-page handout that lists eight items and the patient circles one item to define his/her current level of physical activity -the PACE score (e.g. "I have been thinking of starting to exercise in the next 6 months" = 2, or "I've been doing vigorous exercise 3 or more days per week for the last 6 months or more" = 8). We excluded individuals with a score of '1' as it indicates no intention of starting to exercise within the next 6 months and our intervention was focused on individuals at a higher stage of readiness to exercise.
Measures completed at the baseline visit
Self-efficacy We determined self-efficacy -the patient's selfconfidence to carry out certain activities (e.g. walking for exercise for up to three times per week) using the six-item Self-Efficacy for Managing Chronic Disease scale. 7 Responses for each of the six items ranges from 1 (not at all confident) to 10 (totally confident). The score for the scale is the mean of the six items so the scores range from 1 to 10). This instrument was tested on 605 subjects with chronic disease with a resultant internal consistency reliability coefficient of 0.91. 7 We will identify the association of our routine walking with self-efficacy. 15 Please see http://patienteducation.stanford. edu/research/secd6.html for a copy of this instrument.
The Lifestyle and Clinical Survey The Lifestyle and Clinical Survey (LCS) was administered to ascertain sociodemographics and comorbidities. Reliability evidence for the survey has been found to be excellent with a summary kappa statistic of 0.81 (95% CI 0.78, 0.84). Validity evidence has been found to be very good with a summary kappa statistic of 0.58 (95% CI 0.52, 0.64). 8 Walking Impairment Questionnaire We captured the participant's ability to walk in the community based on results from the validated interviewer-administered Walking Impairment Questionnaire (WIQ). 9 The WIQ estimates walking distance, walking speed, and stair-climbing capacity. The degree of difficulty is ranked on a 0 to 4 Likert scale. Based on patients' responses to the degree of difficulty to walk a predefined distance, walking speed, and to climb stairs, three scores were calculated (0 = lowest, 100 = highest) for each of these parameters.
Medical Outcomes Study -Short Form Survey (SF-36)
To determine health-related quality of life, we used the Medical Outcomes Study -Short Form Survey (SF-36). 10 The SF-36 contains 36 items that measure eight health concepts and health transition. 16 Each subscale is scored from 0 to 100 and a higher score indicates a more positive quality of life for each subscale.
Geriatric Depression Score -Short Form Depressive symptoms are associated with impairment in lower extremity functioning in patients with PAD. 17 We used the validated six-item screening instrument, the Geriatric Depression Score -Short Form, to measure depressive symptoms. This is a 15-item questionnaire and scores range from 1 to 15.
Scores of 10 or higher are considered positive for depression and scores of 5 or higher are suggestive of depression.
Treadmill walking To capture an objective assessment of walking ability, we utilized maximal treadmill walking distance, as based on a graded exercise treadmill test with electrocardiographic monitoring. The graded exercise treadmill test required a constant treadmill speed with modest increases in grade every few minutes; speed is kept constant at 2.0 mph (0.894 m/sec) with increases in grade of 2% every 2 minutes. Following a demonstration by research staff, patients walked on the treadmill until they reached their maximal distance with termination secondary to severe leg discomfort and/or maximal exertion. 18 On reaching the maximal leg discomfort or maximal exertion, patients had a cool down period during which a licensed MD again monitored their blood pressure and heart rate every 5 minutes until a return to baseline. The total distance walked from the time both feet were walking on the belt until the participant asked to stop and the speed of the treadmill was reduced was recorded as the maximal treadmill walking distance.
Six-minute walk test The 6-minute walk test provided an additional objective measure of lower extremity functioning. 19 In contrast to treadmill testing, the 6-minute walk test provides information on the participant's ability to walk in the community. 19 This testing was not a part of the original protocol but was added after the first 59 participants had been enrolled. We have data on 83 participants. We conducted the test by placing two cones 25 feet (7.62 meters) apart in a marked hallway. Participants were instructed to walk as many laps around the cones as possible and to inform the research assistant if and when leg discomfort occurs. Participants will be permitted to stop walking during the test if leg discomfort becomes intolerable but the clock continued during this rest period. At the end of 6 minutes, we recorded the total distance walked.
Statistical analysis
Simple linear regression was used to assess the relationship between self-efficacy with each primary outcome (dependent variable). For multivariable modeling, we used stepwise selection to identify significant variables, allowing variables with p < 0.25 to enter the models and variables with p < 0.10 to stay in the models. Variables considered for inclusion in the models were self-efficacy, sex, age, PACE score, glycosylated hemoglobin (HgbA1c -average blood glucose over the past 3 months), ABI, current smoker, current drinker, congestive heart failure, renal insufficiency, myocardial infarction, transient ischemic attack (TIA), hypertension, and daily antiplatelet use. We also used the Student's t-test to compare self-efficacy, as a dichotomous variable using the baseline mean as the cut-point, with each primary outcome and two additional continuous outcomes (walking distance, as measured by the WIQ, and Physical functioning, as measured by the SF-36). A p-value < 0.05 was deemed statistically significant. SAS V9.1.3 (SAS Institute Inc., Cary, NC, USA) was used to conduct the analyses.
Results
We telephone screened 1744 individuals and 1211 were excluded for the following reasons: no working telephone number, age < 40 years, no diabetes mellitus, prior lower extremity arterial revascularization within the past 3 months, involvement in another trial, no leg symptoms, a PACE score of 1, or not interested. Of the 533 who were eligible for an in-person visit, we excluded 388 either for a lack of objective evidence of PAD or an inability to complete treadmill testing. We enrolled 145 participants and the mean age of the cohort was 66.5 (SD 10.1) years. Forty-five participants (31%) were women and 130 (90%) were European Americans/Caucasians. One hundred and thirty-four (92%) members of the cohort had completed high school and nearly half had an annual household income of $30,000 or more. Additional atherosclerotic risk factors were common: 106 (73%) participants were either former or current smokers and 119 (82%) had a diagnosis of hypertension. One hundred and twenty seven (88%) participants reported daily use of an antiplatelet agent, most commonly aspirin or clopidogrel ( Table 1 ). The mean self-efficacy score was 7.0 (1.86), the mean maximal treadmill walking distance was 418 (259) meters and the mean 6-minute walking distance was 272 (74) meters ( Table 2) .
Based on its mean value, self-efficacy was categorized into two groups: high or low. Participants with a score of less than 7 were defined as having low self-efficacy and participants with a score of 7 or greater were defined as having high self-efficacy. Participants with low self-efficacy had a mean maximal treadmill walking distance of 349 (SD 249) meters as compared to 481 (SD 252) meters for participants with high self-efficacy (p = 0.0020). Participants with lower self-efficacy had a mean 6-minute walking distance of 247 (SD 80) meters while participants with higher self-efficacy had a mean 6-minute walking distance of 293 (SD 61) meters, p = 0.0040 (Table 3) .
Self-efficacy was univariately associated with both maximal treadmill walking distance (coefficient = 34.5; SE = 11.3; p = 0.0027) and 6-minute walking distance (coefficient = 10.7; SE = 4.0; p = 0.0083). In the multiple linear regression model, risk factors associated with maximal treadmill walking distance included self-efficacy, renal insufficiency, and current alcohol use (Table 4 ). We found that self-efficacy was positively associated with maximal treadmill walking distance (p = 0.0036). Similarly, the use of alcohol was positively associated with maximal treadmill walking distance (p = 0.0211). In contrast, renal insufficiency was negatively associated with maximal treadmill walking distance (p = 0.0478). Risk factors associated with the 6-minute walking distance included self-efficacy, PACE score, ABI, and current alcohol use. Specifically, the higher the self-efficacy score, the greater the 6-minute walking distance (p = 0.0061) ( Table 5 ).
Discussion
In a cohort of individuals with diabetes mellitus and PAD, we found that self-efficacy was significantly associated with walking ability. This association, based on measurements of walking distance as captured by the treadmill walking distance and by the 6-minute walk test, remained even after adjustment for comorbidities, social habits, stage of readiness to exercise, and disease severity. To our knowledge, this is the first study to define the association of selfefficacy with objective walking ability in individuals with diabetes mellitus and PAD.
Self-efficacy is a well-known psychosocial mediator for behavior change and a construct within the Social Cognitive Theory. 3, 6, 20 To enhance exercise self-efficacy in individuals with PAD, interventions must address motivators and challenges to maintaining a routine walking program. For example, a patient may have high self-efficacy to walk with a partner or in favorable weather but not alone or in rainy or cold weather. Such issues could be targeted within a counseling intervention.
One prior study has evaluated the association of self-efficacy with promotion of physical activity in individuals with PAD. Specifically, Rejeski et al. 21 found that, among 205 individuals with PAD, self-efficacy was associated with physical activity. Our data add to this work by demonstrating an association of self-efficacy with both treadmill-based and community-based walking ability in individuals with PAD, all of whom have co-existing diabetes mellitus. Aside from work focused on patients with PAD, prior studies [22] [23] [24] [25] [26] [27] have evaluated interventions to increase walking behavior among healthy sedentary adults. Calfas et al. 14 conducted an initial study involving 255 healthy sedentary adults. They sought to determine the efficacy of a 3-5 minute counseling intervention followed by a phone call at 2 weeks. The intervention targeted self-efficacy. Patients who received the intervention significantly increased their weekly walking by 37 minutes compared to an increase of only 7 minutes for controls. In a subsequent study by Calfas et al. 28 and also involving healthy sedentary adults (n = 173), trained phone counselors delivered behavioral counseling to increase self-efficacy and motivate change. Physical activity again improved in this subsequent study. These prior studies also highlight the importance of self-efficacy to motivate physical activity in sedentary adults. Our data add to this previous work by highlighting the important association of self-efficacy with walking ability in individuals with diabetes mellitus and symptomatic PAD.
Specific to individuals with diabetes mellitus, walking, as a form of exercise, can improve glucose control and quality of life. 29 For individuals with PAD, walking is the best non-invasive therapy to improve walking distance but most prior studies of walking therapy have focused on supervised treadmill walking -walking therapy conducted within a clinical setting with supervision by a trained clinician. 30, 31 Home-based walking is a potentially excellent alternative to supervised treadmill walking, but only if patients are motivated to adhere to therapy. Prior studies have evaluated the efficacy of home-based walking in patients with PAD [32] [33] [34] [35] [36] ; with the exception of a pilot trial, 32 none have utilized strategies to motivate behavior change. The findings from our study suggest that self-efficacy should be a target for interventions to promote walking in individuals with PAD, including the high-risk group of individuals with co-existing diabetes mellitus.
Self-efficacy was positively correlated with walking impairment and individuals with higher self-efficacy had less walking impairment. Similarly, self-efficacy was associated with a higher score on the physical functioning domain of the SF-36. The association of self-efficacy with walking ability remained even after adjusting for renal insufficiency. Renal insufficiency was negatively associated. Renal insufficiency is a known risk factor for coronary heart disease and stroke. 37, 38 Individuals with renal insufficiency are also more likely to have coexisting and more severe PAD. Our findings highlight that even with renal insufficiency, self-efficacy can have a positive impact on walking ability. Similarly, for individuals who drink alcohol, self-efficacy remains significantly associated with walking ability after adjusting for this covariate.
Limitations of the study include the use of a self-efficacy instrument that was not specific to physical activity. Because our cohort had both diabetes mellitus and PAD, we chose a self-efficacy instrument which assessed confidence to manage multiple aspects of a chronic disease. We acknowledge that our findings only reflect baseline data. However, the significant association of self-efficacy with walking ability remained even within the multivariable model which highlights the importance of this variable. An additional limitation was our low enrollment of minority participants. We utilized various methods to increase minority participation (e.g. announcements on radio stations whose listening audiences were largely minorities, attendance at churches whose members were minorities) but, given that most of our assessments required a visit to the university and individuals within the community were not as interested in traveling to our site, fewer than 10% of our participants were ethnic minorities.
In conclusion, our data provide a target for behavioral interventions (i.e. self-efficacy) to improve walking ability in individuals with diabetes mellitus and PAD. Further research is needed to target this psychosocial variable in exercise interventions designed for individuals with PAD.
